| 02/03/20 | Dermira : Form 15-12B - Securities Registration Termination | PU |
| 20/02/20 | Dermira : SEC Filing - S-8 POS | PU |
| 20/02/20 | Dermira : SEC Filing - POS AM | PU |
| 20/02/20 | Dermira : Lilly Completes Acquisition of Dermira | PR |
| 12/02/20 | Dermira : Amended tender offer statement by Third Party | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Thompson
PSD | President | - | - |
Carly Loeb
COO | Chief Operating Officer | - | 01/01/2018 |
Gary Thompson
CMP | Compliance Officer | - | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Gordon Brooks
BRD | Director/Board Member | - | 20/02/2020 |
Philip Johnson
BRD | Director/Board Member | 62 | 20/02/2020 |
Michael Thompson
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/02/20 | Don | Chief Medical Officer; Director | 562,325 | 1.0281% | ||
| 20/02/20 | Issuer sale | Director | 68,377 | 0.1250% | ||
| 20/02/20 | Issuer sale | Chief Financial Officer | 496,361 | 0.9075% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.11% | - | - | 1.03B | |
| +2.35% | +0.77% | +29.92% | +85.38% | 55.23B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.75B | |
| -2.27% | +1.97% | -15.27% | -16.33% | 23.48B | |
| -3.55% | -8.32% | -8.63% | +343.73% | 22B | |
| +2.49% | -1.27% | +15.99% | -10.53% | 19.78B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.44B | |
| +0.58% | -7.23% | +24.50% | +519.07% | 14.66B | |
| -4.88% | -3.43% | +47.63% | +171.28% | 14.07B | |
| +3.41% | -7.83% | +161.76% | +284.91% | 13.02B | |
| Average | -0.13% | -1.43% | +34.50% | +156.36% | 25.94B | |
| Weighted average by Cap. | +0.15% | +0.09% | +27.54% | +120.89% |
Employees
-
